GlassScriptPhysician profile
Tina Lonneman
NPI 1982782959
$520.22
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $170 · 2023: $90.46 · 2024: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $217.93 | 2021-2024 | Ligasure, Signia, Minimed 780g |
| Radius Health, INC. | $72.32 | 2021-2022 | |
| Novo Nordisk INC | $37.80 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $32.58 | 2021 | |
| Sanofi-Aventis U.S. LLC | $30.53 | 2022 | |
| Amryt Pharma Holdings LTD | $27.07 | 2022 | |
| Pfizer INC. | $20.00 | 2021 | |
| Lilly USA, LLC | $15.84 | 2022 | |
| Ibsa Pharma INC. | $14.63 | 2022 | |
| Clarus Therapeutics INC. | $13.54 | 2021 | |
| Antares Pharma, INC. | $13.25 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.90 | 2022 | |
| Abbvie INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Lonneman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.